Abstract:Chenhao Xing, 1 Yamin Lu, 2 Guangxia Liu, 2 Fang Chen, 2 Zhan Hou, 2 Yiwen Zhang 2 1 Graduate School of Hebei North University, Hebei North University, Zhangjiakou, Hebei, People's Republic of China; 2 Department of Nuclear Medicine, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China Correspondence: Yamin Lu, Department of Nuclear Medicine, Hebei General Hospital, Shijiazhuang, 050051, People's Republic of China, Tel +86 15833956939, Email Objective: The purpose of the study was to investigate the expression levels and correlation of inflammatory factors such as miR-377-3p and TGF-β in patients with diabetic kidney disease (DKD), and to investigate the regulatory mechanism of transfection of miR-377-3p on the inflammatory response of HK-2 cell induced by high glucose. Methods: According to UACR, patients were divided into normal albuminuria group (Con, n = 29), microalbuminuria group (Micro, n = 31) and macroalbuminuria group (Macro, n = 30), analyzed the correlation and influencing factors between DKD and inflammatory factor. HK-2 cells were randomly divided into four groups: normal control group (NC), high glucose group (HG), miR-377-3p overexpression group (MIN), and miR-377-3p inhibition group (IN). After transfection of miR-377-3p mimics and inhibitors, the contents of TGF-β, IL-6 and IL-18 were detected by RT-PCR and Western blot. Results: The levels of miR-377-3p, TGF-β, IL-6 and IL-18 in both Micro group and Macro group were significantly higher than those in Con group (P < 0.05); Pearson correlation analysis showed that miR-377-3p was positively correlated with UACR, TG, TGF-β, IL-6 and IL-18, and negatively correlated with GFR (P < 0.05). Cell experiment: RT-PCR and Western blot results showed that miR-377-3p, TGF-β, IL-6 and IL-18 in HG group were significantly higher than those in NC group (P < 0.05). After transfection with miR-377-3p inhibitor, the levels of miR-377-3p, TGF-β, IL-6 and IL-18 in IN group were significantly decreased compared with HG group and MIN group. Conclusion: miR-377-3p expression was elevated both in serum of DKD patients and in HK-2 cells with high glucose induced injury, overexpression of miR-377-3p exacerbates the damage to HK-2 cells and promotes the progression of DKD. Silencing miR-377-3p can potentially regulate the levels of inflammatory factors in HK-2 cells by targeting downregulation of TGF-β expression, thereby mitigating the damage to HK-2 cells and delaying the development of diabetic kidney disease. Keywords: miR-377-3p, transforming growth factor beta, interleukin 6, interleukin 18, renal tubular epithelial cells In recent years, with the improvement of residents' living standards and the change of lifestyle, the incidence of diabetes has increased year by year. As a common complication of diabetes, the incidence of diabetic kidney disease (DKD) also increases with the increase of diabetic patients. 1 Renal tubule injury is considered to be the main cause of the pathogenesis of DKD. 2 Sustained stimulation of high glucose causes damage to renal tubular epithelial cells, leading to the secretion of several inflammatory cytokines, such as interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), transforming growth factor-β (TGF-β) and vascular cell adhesion molecule-1 (VCAM-1), which promote the inflammatory response. Activate TGF-β and other molecular pathways, 3,4 thereby triggering interstitial inflammation and fibrosis, and mediating the occurrence and development of diabetic kidney disease. 5 MicroRNAs (miRNAs) are important regulators of gene expression in many diseases and can affect many cellular processes, including cell proliferation, differentiation, and apoptosis. 2 It has been reported that miRNA-615-3p is involved in the inflammatory response related to osteoarthritis by increasing the expression of IL-1β, IL-6, interleukin-α and other inflammatory cytokines. 6 miR-10b-5p is one of the earliest miRNAs found to be abnormal in human cancer, and it is involved in inflammation control and inflammation-related diseases by regulating T cells. 7 miR-377 is a new pro-inflammatory factor that can regulate cellular inflammatory response and insulin resistance. Studies have reported that miR-377-3p is closely related to the pathogenesis of DKD. 8 Wang et al believed that miR-377 could increase the expression of matrix proteins and fibronectin, leading to renal tubulointerstitial inflammation and renal fibrosis. 9 TGF-β signaling pathway is the key to the occurrence of diabetic kidney disease and renal tubulointerstitial fibrosis. There may be a regulatory correlation betwee -Abstract Truncated-

RUNX3 alleviates mitochondrial dysfunction and tubular damage by inhibiting TLR4/NF‐κB signalling pathway in diabetic kidney disease

Krppel‑like Factor4 Ameliorates Diabetic Kidney Disease by Activating Autophagy Via the Mtor Pathway

Smad3 Promotes AKI Sensitivity in Diabetic Mice Via Interaction with P53 and Induction of NOX4-dependent ROS Production

FOXO3a Protects Against Kidney Injury in Type II Diabetic Nephropathy by Promoting Sirt6 Expression and Inhibiting Smad3 Acetylation.

DeSUMOylation of RBMX regulates exosomal sorting of cargo to promote renal tubulointerstitial fibrosis in diabetic kidney disease

Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis

ATF5 regulates tubulointerstitial injury in diabetic kidney disease via mitochondrial unfolded protein response

Alpha lipoamide inhibits diabetic kidney fibrosis via improving mitochondrial function and regulating RXRα expression and activation

CUL3 induces mitochondrial dysfunction via MRPL12 ubiquitination in renal tubular epithelial cells

Tribbles pseudokinase 3 promoted renal fibrosis by regulating the expression of DNA damage-inducible transcript 3 in diabetic nephropathy

LncTUG1 ameliorates renal tubular fibrosis in experimental diabetic nephropathy through the miR-145-5p/dual-specificity phosphatase 6 axis

LncRNA TUG1 ameliorates diabetic nephropathy via inhibition of PU.1/RTN1 signaling pathway

MiRNA-133a-3p Attenuates Renal Tubular Epithelial Cell Injury via Targeting MALM1 and Suppressing the Notch Signaling Pathway in Diabetic Nephropathy

METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy

METTL3 enhances NSD2 mRNA stability to reduce renal impairment and interstitial fibrosis in mice with diabetic nephropathy

FOXM1-activated SIRT4 inhibits NF-κB signaling and NLRP3 inflammasome to alleviate kidney injury and podocyte pyroptosis in diabetic nephropathy

miR-124-3p improves mitochondrial function of renal tubular epithelial cells in db/db mice

METTL14 promotes the development of diabetic kidney disease by regulating m6A modification of TUG1

RIPK3 blockade attenuates tubulointerstitial fibrosis in a mouse model of diabetic nephropathy

RUNX3-activated apelin signaling inhibits cell proliferation and fibrosis in diabetic nephropathy by regulation of the SIRT1/FOXO pathway

The Expression of miR-377-3p in Patients with DKD and the Regulatory Mechanism of miR-377-3p on the Inflammatory Response of HK-2 Cells Through TGF-β